eXIthera Pharmaceuticals' Seed VC Round

eXIthera Pharmaceuticals raised a round of funding on July 31, 2012. Investors include Access BridgeGap Ventures.

eXIthera Pharmaceuticals is a an early stage biotech company focused on developing small molecule pharmaceuticals to inhibit Factor Xla, an important enzyme in the blood coagulation pathway.…

Articles about eXIthera Pharmaceuticals' Seed VC Round: